Summary
Studies with the atypical muscarinic antagonist pirenzepine provide convincing evidence for the classification of muscarinic acetylcholine receptors (mAChRs) into two subtypes, M1 and M2. The present study examines the heterogeneity of the M2 subtype employing the newly developed competitive muscarinic antagonist, AFDX-116. Comparison of the binding affinities of pirenzepine, atropine, and AFDX-116 to mAChRs in microsomes from the rabbit cerebral cortex, heart, and iris smooth muscle shows that iris mAChRs, which are pharmacologically of the M2 subtype, can be distinguished from M2 cardiac receptors based on their affinity for AFDX-116. These results are consistent with the hypothesis that the M2 receptor subtype consists of a heterogeneous population of receptors.
Similar content being viewed by others
Abbreviations
- mAChRs:
-
Muscarinic Acetylcholine Receptors
- CCh:
-
Carbachol
- NMS:
-
N-Methylscopolamine
- AFDX-116:
-
11-[[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-6Hpyrido[2,3-b][1,4]benzodiazepine-6-one
References
Brown D: Nature 319, 358–359, 1986
Gilman AG: Cell 36, 577–579, 1984
Abdel-Latif AA: Pharmacol Rev 38, 227–272, 1986
Harden TK, Tanner LI, Martin MW Nakahata N, Hughes AR, Hepler JR, Evans T, Masters SB, Brown JH: Trends in Pharmacol Sci Suppl: Muscarinic Receptors II, 14–18, 1986
Hammer R, Berrie CP, Birdsall NJM, Burgen ASV, Hulme EC: Nature 283, 90–92, 1980
Watson M, Yamamura HI, Roeske WR: Life Sci 32, 3001–3011, 1983
Hammer R, Giachetti A: Life Sci 31, 2991–2998, 1982
Bonner TI, Buckley NJ, Young AC, Brann MR: Science 237, 527–532, 1987
Kubo T, Fukada K, Mikami A, Maeda A, Takahashi H, Mishini M, Haga T, Haga K, Ichiyama A, Kangaw K, Kojima M, Matsuo H, Hirose T, Numa S: Nature 323, 411–416, 1986
Peralta EG, Winslow JW, Peterson GL, Smith DH, Ashkenazi A, Ramachandran J, Schimerlik MI, Capon DJ: Science 236, 600–605, 1987
Howe PH, Akhtar RA, Naderi S, Abdel-Latif AA: J Pharmacol Exp Therap 239, 574–583, 1986
Akhtar RA, Honkanen RE, Howe PH, Abdel-Latif AA: J Pharmacol Exp Therap 243, 624–632, 1987
Micheletti R, Montagna E, Giachetti A: J Pharmacol Exp Therap 241, 628–639, 1987
Hammer R, Giraldo E, Schiava GB, Monferini E, Ladinsky H: Life Sci 38, 1653–1662, 1986
Giraldo E, Hammer R, Ladinsky H: Life Sci 40, 833–840, 1987
Giachetti A, Micheletti R, Montagna E: Life Sci 38, 1663–1672, 1986
Yamamura HI, Snyder SH: Proc Natl Acad Sci USA 71, 1725–1729, 1974
Munson PJ, Rodbard D: Analyt Biochem 107, 220–239, 1980
Arunlakshana O, Schild HO: Br J Pharmacol 14, 48–58, 1959
Duckles SP, Yamamura HI, Lee V: Life Sci 40, 1507–1511, 1987
Hammer R: Scand J Gastrointest 72, 59–67, 1982
Honkanen RE, Abdel-Latif AA: Biochem Pharmacol. In press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Honkanen, R.E., Abdel-Latif, A.A. AFDX-116 discriminates between muscarinic M2 receptors of the heart and the iris smooth muscle. Mol Cell Biochem 82, 131–135 (1988). https://doi.org/10.1007/BF00242528
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00242528